Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Inhibitor Therapeutics, Inc.

CIK 1042418Updated Nov 17, 2026

Name history
HedgePath Pharmaceuticals, Inc. · through Aug 12, 2019COMMONWEALTH BIOTECHNOLOGIES INC · through May 20, 2013

INTI price & chart

Provider market data

Loading TradingView…

OTC:INTI on TradingView ↗

TradingView · Data may be delayed

Financials

FY 2025 · USD
Revenue— · FY 2025
Net income-3,300,337USD · FY 2025
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

Operating income-3,426,653USD · FY 2025
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

Diluted EPS-0.02USD per share · FY 2025
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD3,135,167
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

6,451,442
Source

10-Q · 2024-11-12 · 0001493152-24-044473

As of 2024-09-30

637,190
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

3,907,662
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

7,173,367
Source

10-Q · 2024-08-06 · 0001493152-24-030381

As of 2024-06-30

1,433,363
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

4,505,267
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

7,794,220
Source

10-Q · 2024-05-13 · 0001493152-24-018805

As of 2024-03-31

2,511,307
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

5,694,658
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

8,949,155
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

11,975,124
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD2,976,658
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

6,378,304
Source

10-Q · 2024-11-12 · 0001493152-24-044473

As of 2024-09-30

515,758
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

3,737,903
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

7,098,742
Source

10-Q · 2024-08-06 · 0001493152-24-030381

As of 2024-06-30

1,290,978
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

4,321,894
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

7,681,821
Source

10-Q · 2024-05-13 · 0001493152-24-018805

As of 2024-03-31

2,375,493
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

5,606,863
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

8,839,912
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

11,951,224
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Assets, CurrentUSD3,064,086
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

6,451,442
Source

10-Q · 2024-11-12 · 0001493152-24-044473

As of 2024-09-30

586,806
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

3,829,928
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

7,173,367
Source

10-Q · 2024-08-06 · 0001493152-24-030381

As of 2024-06-30

1,375,953
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

4,420,999
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

7,794,220
Source

10-Q · 2024-05-13 · 0001493152-24-018805

As of 2024-03-31

2,447,000
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

5,694,658
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

8,949,155
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

11,975,124
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD87,428
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

73,138
Source

10-Q · 2024-11-12 · 0001493152-24-044473

As of 2024-09-30

71,048
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

92,025
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

74,625
Source

10-Q · 2024-08-06 · 0001493152-24-030381

As of 2024-06-30

84,975
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

99,105
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

112,399
Source

10-Q · 2024-05-13 · 0001493152-24-018805

As of 2024-03-31

71,507
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

87,795
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

109,243
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

—
Operating Lease, Right-of-Use AssetUSD71,081
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

—50,384
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

77,734
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

—57,410
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

84,268
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

—64,307
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

———
LIABILITIES AND EQUITY
LiabilitiesUSD3,131,714
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

3,044,559
Source

10-Q · 2024-11-12 · 0001493152-24-044473

As of 2024-09-30

3,196,460
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

3,192,025
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

3,035,527
Source

10-Q · 2024-08-06 · 0001493152-24-030381

As of 2024-06-30

3,411,700
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

3,153,073
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

3,155,850
Source

10-Q · 2024-05-13 · 0001493152-24-018805

As of 2024-03-31

3,803,219
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

3,709,618
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

3,665,164
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

3,678,782
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD17,257
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

17,232
Source

10-Q · 2024-11-12 · 0001493152-24-044473

As of 2024-09-30

17,379
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

17,257
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

17,232
Source

10-Q · 2024-08-06 · 0001493152-24-030381

As of 2024-06-30

17,257
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

17,232
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

17,232
Source

10-Q · 2024-05-13 · 0001493152-24-018805

As of 2024-03-31

17,257
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

17,232
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

17,202
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

17,179
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Additional Paid in CapitalUSD54,110,425
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

54,087,065
Source

10-Q · 2024-11-12 · 0001493152-24-044473

As of 2024-09-30

54,143,303
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

54,110,425
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

54,087,065
Source

10-Q · 2024-08-06 · 0001493152-24-030381

As of 2024-06-30

54,110,425
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

54,087,065
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

54,085,905
Source

10-Q · 2024-05-13 · 0001493152-24-018805

As of 2024-03-31

54,110,425
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

54,087,065
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

54,046,845
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

—
Retained Earnings (Accumulated Deficit)USD-54,124,229
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

-50,697,414
Source

10-Q · 2024-11-12 · 0001493152-24-044473

As of 2024-09-30

-56,719,952
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

-53,412,045
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

-49,966,457
Source

10-Q · 2024-08-06 · 0001493152-24-030381

As of 2024-06-30

-56,106,019
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

-52,752,103
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

-49,464,767
Source

10-Q · 2024-05-13 · 0001493152-24-018805

As of 2024-03-31

-55,419,594
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

-52,119,257
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

-48,780,056
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

-45,753,921
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD3,453
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

3,406,883
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2024-09-30

-2,559,270
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

715,637
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2025-06-30

4,137,840
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2024-06-30

-1,978,337
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

1,352,194
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2025-03-31

4,638,370
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2024-03-31

-1,291,912
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

1,985,040
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

5,283,991
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

8,296,342
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Additional Paid in Capital, Common StockUSD———————————54,033,084
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Liabilities and EquityUSD3,135,167
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

6,451,442
Source

10-Q · 2024-11-12 · 0001493152-24-044473

As of 2024-09-30

637,190
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

3,907,662
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

7,173,367
Source

10-Q · 2024-08-06 · 0001493152-24-030381

As of 2024-06-30

1,433,363
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

4,505,267
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

7,794,220
Source

10-Q · 2024-05-13 · 0001493152-24-018805

As of 2024-03-31

2,511,307
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

5,694,658
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

8,949,155
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

11,975,124
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD87,533
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

44,559
Source

10-Q · 2024-11-12 · 0001493152-24-044473

As of 2024-09-30

174,894
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

139,961
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

35,527
Source

10-Q · 2024-08-06 · 0001493152-24-030381

As of 2024-06-30

382,320
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

94,712
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

155,850
Source

10-Q · 2024-05-13 · 0001493152-24-018805

As of 2024-03-31

766,330
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

709,618
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

665,164
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

678,782
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Accounts Payable, CurrentUSD19,646
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

1,706
Source

10-Q · 2024-11-12 · 0001493152-24-044473

As of 2024-09-30

139,052
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

106,249
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

18,803
Source

10-Q · 2024-08-06 · 0001493152-24-030381

As of 2024-06-30

319,803
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

36,702
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

111,916
Source

10-Q · 2024-05-13 · 0001493152-24-018805

As of 2024-03-31

51,521
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

15,896
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

33,731
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

145,161
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD40,432
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

42,853
Source

10-Q · 2024-11-12 · 0001493152-24-044473

As of 2024-09-30

9,580
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

7,725
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

16,724
Source

10-Q · 2024-08-06 · 0001493152-24-030381

As of 2024-06-30

33,536
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

32,023
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

43,934
Source

10-Q · 2024-05-13 · 0001493152-24-018805

As of 2024-03-31

690,085
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

693,722
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

631,433
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

122,621
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Deferred Revenue, NoncurrentUSD3,000,000
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

3,000,000
Source

10-Q · 2024-11-12 · 0001493152-24-044473

As of 2024-09-30

3,000,000
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

3,000,000
Source

10-Q · 2025-08-13 · 0001641172-25-023465

As of 2025-06-30

3,000,000
Source

10-Q · 2024-08-06 · 0001493152-24-030381

As of 2024-06-30

3,000,000
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

3,000,000
Source

10-Q · 2025-05-14 · 0001641172-25-010110

As of 2025-03-31

3,000,000
Source

10-Q · 2024-05-13 · 0001493152-24-018805

As of 2024-03-31

3,000,000
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

3,000,000
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

3,000,000
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

3,000,000
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Deferred Tax Liabilities, NetUSD——————————55,000
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

55,000
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD————————23,385
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

40,250
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

13,784
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

—
Net Cash Provided by (Used in) Operating ActivitiesUSD——————-1,084,515
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

-1,284,969
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

-3,231,370
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

-3,233,049
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

-2,700,312
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

11,740,598
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————————-411,000
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

180,000
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-1,084,515
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

-1,284,969
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

-3,231,370
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

-3,233,049
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

-3,111,312
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

11,920,598
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——2,976,658
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2025-09-30

6,378,304
Source

10-Q · 2025-11-13 · 0001493152-25-022178

As of 2024-09-30

515,758
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2026-06-30

3,737,903
Source

10-Q · 2026-08-14 · 0001493152-26-038288

As of 2025-06-30

1,290,978
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2026-03-31

4,321,894
Source

10-Q · 2026-05-15 · 0001493152-26-023622

As of 2025-03-31

2,375,493
Source

10-K · 2026-03-26 · 0001493152-26-012751

As of 2025-12-31

5,606,863
Source

10-K · 2025-03-28 · 0001641172-25-001190

As of 2024-12-31

8,839,912
Source

10-K · 2024-03-29 · 0001493152-24-011973

As of 2023-12-31

11,951,224
Source

10-K · 2023-03-31 · 0001493152-23-010383

As of 2022-12-31

Supplemental disclosure of cash flow information:
Income Taxes Paid, NetUSD——————————53,088
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

—
Additional Financial Items
Gain (Loss) Related to Litigation SettlementUSD———————————12,619,492
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——363,426
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2025-07-01 to 2025-09-30

443,575
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2024-07-01 to 2024-09-30

395,033
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2026-04-01 to 2026-06-30

370,150
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2025-04-01 to 2025-06-30

355,070
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

438,493
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

1,729,935
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

1,974,859
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

2,023,913
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

651,776
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD———————————55,109
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-712,184
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2025-07-01 to 2025-09-30

-730,957
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2024-07-01 to 2024-09-30

-613,933
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2026-04-01 to 2026-06-30

-659,942
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2025-04-01 to 2025-06-30

-686,425
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

-632,846
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

-3,300,337
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

-3,339,201
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

-3,026,135
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

12,106,230
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD——————————-3,026,135
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

11,917,188
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Operating ExpensesUSD——741,215
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2025-07-01 to 2025-09-30

813,196
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2024-07-01 to 2024-09-30

618,597
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2026-04-01 to 2026-06-30

695,773
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2025-04-01 to 2025-06-30

695,632
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

674,551
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

3,426,653
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

3,657,409
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

3,404,979
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

657,926
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Operating Income (Loss)USD——-741,215
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2025-07-01 to 2025-09-30

-813,196
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2024-07-01 to 2024-09-30

-618,597
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2026-04-01 to 2026-06-30

-695,773
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2025-04-01 to 2025-06-30

-695,632
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

-674,551
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

-3,426,653
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

-3,657,409
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

-3,404,979
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

-657,926
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD——————————-3,026,135
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

12,161,339
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD———————————55,109
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-712,184
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2025-07-01 to 2025-09-30

-730,957
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2024-07-01 to 2024-09-30

-613,933
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2026-04-01 to 2026-06-30

-659,942
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2025-04-01 to 2025-06-30

-686,425
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

-632,846
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

-3,300,337
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

-3,339,201
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

-3,026,135
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

12,106,230
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——0
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2025-07-01 to 2025-09-30

0
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2024-07-01 to 2024-09-30

0
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2026-04-01 to 2026-06-30

0
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2025-04-01 to 2025-06-30

0
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

-0.02
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

-0.02
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

-0.02
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

0.03
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——0
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2025-07-01 to 2025-09-30

0
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2024-07-01 to 2024-09-30

0
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2026-04-01 to 2026-06-30

0
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2025-04-01 to 2025-06-30

0
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

-0.02
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

-0.02
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

-0.02
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

0.03
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——172,573,545
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2025-07-01 to 2025-09-30

172,323,545
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2024-07-01 to 2024-09-30

173,307,525
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2026-04-01 to 2026-06-30

172,573,545
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2025-04-01 to 2025-06-30

172,573,545
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

172,323,545
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

172,511,901
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

172,262,889
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

171,950,108
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

366,183,697
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——172,573,545
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2025-07-01 to 2025-09-30

172,323,545
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2024-07-01 to 2024-09-30

173,307,525
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2026-04-01 to 2026-06-30

172,573,545
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2025-04-01 to 2025-06-30

172,573,545
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

172,323,545
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

172,511,901
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

172,262,889
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

171,950,108
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

367,776,961
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Additional Financial Items
Gain (Loss) Related to Litigation SettlementUSD———————————12,619,492
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——363,426
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2025-07-01 to 2025-09-30

443,575
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2024-07-01 to 2024-09-30

395,033
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2026-04-01 to 2026-06-30

370,150
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2025-04-01 to 2025-06-30

355,070
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

438,493
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

1,729,935
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

1,974,859
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

2,023,913
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

651,776
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Interest and Other IncomeUSD——29,031
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2025-07-01 to 2025-09-30

82,239
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2024-07-01 to 2024-09-30

4,664
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2026-04-01 to 2026-06-30

35,831
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2025-04-01 to 2025-06-30

9,207
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

41,705
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

126,316
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

318,208
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

378,844
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

—
Interest ExpenseUSD———————————23,234
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD——————————-3,026,135
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

11,917,188
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Operating ExpensesUSD——741,215
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2025-07-01 to 2025-09-30

813,196
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2024-07-01 to 2024-09-30

618,597
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2026-04-01 to 2026-06-30

695,773
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2025-04-01 to 2025-06-30

695,632
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

674,551
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

3,426,653
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

3,657,409
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

3,404,979
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

657,926
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Preferred Stock Dividends, Income Statement ImpactUSD———————————189,042
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD——377,789
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2025-07-01 to 2025-09-30

369,621
Source

10-Q · 2025-11-13 · 0001493152-25-022178

2024-07-01 to 2024-09-30

223,564
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2026-04-01 to 2026-06-30

325,623
Source

10-Q · 2026-08-14 · 0001493152-26-038288

2025-04-01 to 2025-06-30

340,562
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2026-01-01 to 2026-03-31

236,058
Source

10-Q · 2026-05-15 · 0001493152-26-023622

2025-01-01 to 2025-03-31

1,696,718
Source

10-K · 2026-03-26 · 0001493152-26-012751

2025-01-01 to 2025-12-31

1,682,550
Source

10-K · 2025-03-28 · 0001641172-25-001190

2024-01-01 to 2024-12-31

1,381,066
Source

10-K · 2024-03-29 · 0001493152-24-011973

2023-01-01 to 2023-12-31

6,150
Source

10-K · 2023-03-31 · 0001493152-23-010383

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

ex99-1.htm · 8-K · 2026-04-01

EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome Company outlines near-term pharmacokinetic milestones, highlights amorphous formulation strategy, and announces planned global patent filing TAMPA, Fla., March 31, 2026 - Inhibitor Therapeutics, Inc. (OTCQB: INTI) (“Inhibitor” or the “Company”), today provided an update on its ongoing pharmacokinetic (PK) clinical program supporting the …

8-K · 2026-04-01 · 0001493152-26-014517

Read attachment ↗
ex4-1.htm · 8-K · 2026-02-24

EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 EXECUTION VERSION THE WARRANT REPRESENTED BY THIS CERTIFICATE AND THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES…

8-K · 2026-02-24 · 0001493152-26-007821

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.